Related Experiment Video
Updated: Oct 12, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 and Diabetes
Virginia Bellido1, Antonio Pérez2,3
1Endocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Insights
COVID-19 significantly impacts diabetes mellitus (DM) management, often leading to poor glycemic control. This review examines pandemic-related challenges and strategies for effective diabetes care, including telemedicine.
Area of Science:
- Endocrinology
- Infectious Diseases
- Public Health
Background:
- Diabetes mellitus (DM) is a common comorbidity in COVID-19 patients, associated with a worse prognosis.
- The specific mechanisms linking COVID-19 severity to DM remain unclear, but inadequate glycemic control is frequently observed in hospitalized patients.
- Healthcare professionals may lack specialized diabetes management experience, and infection control measures can hinder optimal glucose monitoring and care.
Purpose of the Study:
- To analyze the influence of COVID-19 on diabetes mellitus glycemic control.
- To assess diabetes management strategies and drug therapies during the pandemic, considering lifestyle factors and patient severity.
- To evaluate the role of telemedicine in managing diabetes during and after the COVID-19 pandemic.
Main Methods:
- Review of existing literature on COVID-19 and diabetes mellitus.
- Analysis of factors affecting glycemic control in diabetic patients during the pandemic.
- Assessment of management approaches for hospitalized and critically ill diabetic COVID-19 patients.
- Consideration of telemedicine applications in diabetes care.
Main Results:
- COVID-19 poses significant challenges to maintaining adequate glycemic control in individuals with diabetes.
- Pandemic-related restrictions and healthcare system strains complicate diabetes management, affecting diet, exercise, and medication adherence.
- Telemedicine emerges as a crucial tool for remote monitoring and management of diabetes in COVID-19 patients.
Conclusions:
- Effective clinical care for diabetic COVID-19 patients requires integrated approaches, including screening, education, and diligent monitoring.
- Adapting diabetes management strategies to pandemic conditions, utilizing telemedicine, is essential for improving patient outcomes.
- Future diabetes care models should incorporate lessons learned from the pandemic to enhance resilience and accessibility.
Abstract:
Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

